• Subscribe
  • Magazine
  • Past Issues
  • Surveys
  • Industry Statistics
  • About Us
  • Members Only
  • Best Places to Work
    • Recent Quotes
    My Watchlist
    Indicators
    PennEnergy Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Cytokinetics (NQ: CYTK )

    60.14 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, May 21, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open 60.14
    Bid (Size) 59.07 (2)
    Ask (Size) 61.75 (4)
    Prev. Close 60.14
    Today's Range 60.14 - 60.14
    52wk Range 25.98 - 110.25
    Shares Outstanding 95,640,600
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    10 Health Care Stocks Whale Activity In Today's Session
    Via Benzinga
    Cytokinetics Reveals More From The Study That Boosted Shares 83% In A Day
    The company is hoping to take on Bristol Myers Squibb's Camzyos, a treatment for obstructive HCM. 
    Via Investor's Business Daily

    Performance

    YTD
    -28.51%
    -28.51%
    1 Month
    -9.28%
    -9.28%
    3 Month
    -21.78%
    -21.78%
    6 Month
    +89.48%
    +89.48%
    1 Year
    +69.70%
    +69.70%

    More News

    Read More
    CYTK Stock Earnings: Cytokinetics Misses EPS, Misses Revenue for Q1 2024
    Via InvestorPlace
    Biotech Breakthroughs: 7 Stocks Driving the Next Wave in Healthcare
    Via InvestorPlace
    (CYTK) - Analyzing Cytokinetics's Short Interest
    Via Benzinga
    $100 Invested In Cytokinetics 5 Years Ago Would Be Worth This Much Today
    Via Benzinga
    2 Incredible Growth Stocks to Buy Right Now
    Via The Motley Fool
    Here's How Much $100 Invested In Cytokinetics 10 Years Ago Would Be Worth Today
    Via Benzinga
    3 Biotech Stocks to Buy on the Dip: April 2024
    Via InvestorPlace
    7 Biotech Stocks Ready to Ride the Sector’s Resurgence
    Via InvestorPlace
    Masters In Trading - Saturday, March 16
    Via Talk Markets
    7 Biotech Stocks to Buy as Sector Rotation Ramps Up
    Via InvestorPlace
    Super Micro, Deckers To Join S&P 500 Index
    Via Investor's Business Daily
    Topics Stocks
    Exposures US Equities
    Unpacking the Latest Options Trading Trends in Cytokinetics
    Via Benzinga
    Here's How Much $1000 Invested In Cytokinetics 10 Years Ago Would Be Worth Today
    Via Benzinga
    Earnings Scheduled For February 27, 2024
    Via Benzinga
    Overbought, Overextended - What's The Buzz In S&P 500 Now?
    Via Talk Markets
    Topics Stocks
    Exposures US Equities
    Here's How Much $1000 Invested In Cytokinetics 5 Years Ago Would Be Worth Today
    Via Benzinga
    3 Biotech Stocks to Buy for the Next Bull Run: February 2024
    Via InvestorPlace
    How Cytokinetics Overcame Two Setbacks And Doubled Its Stock Price Over A Month
    Via Investor's Business Daily
    Banco Santander, Lloyds Banking And Other Big Stocks Moving Lower In Monday's Pre-Market Session
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Here's How Much $100 Invested In Cytokinetics 5 Years Ago Would Be Worth Today
    Via Benzinga
    3 Healthcare Stocks at 52-Week Lows: Buy or Bye?
    Via InvestorPlace
    Biotech Playbook: Small Caps Show Momentum Peaking During
    Via Talk Markets
    10 Health Care Stocks With Whale Alerts In Today's Session
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.